Form 4: Salesforce CFO Amy Weaver Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Amy Weaver, President and CFO of Salesforce, exercised stock options and sold shares of common stock on February 3, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On February 3, 2025, Amy Weaver, the President and CFO of Salesforce, executed transactions involving Salesforce common stock.
- Weaver exercised non-qualified stock options to acquire 5,945 shares at $215.17 and 276 shares at $218.21.
- Simultaneously, Weaver sold 6,221 shares of common stock at $335.94.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 24, 2024.
- Following these transactions, Weaver directly owns 46,750 shares of Salesforce common stock and holds options for 58,097 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
This filing is a routine disclosure of insider transactions and is a common practice for executives at publicly traded companies. The use of a 10b5-1 plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a significant component.
- The vesting schedules and exercise prices are typical for stock option grants in the tech industry.
- The use of 10b5-1 trading plans is a standard practice among executives to manage their stock holdings and avoid potential insider trading accusations.
- Comparable companies such as Microsoft, Oracle, and Adobe also have executives who regularly file Form 4s for similar transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares in the open market.
- The exercise of stock options could dilute existing shareholders' equity, although the effect is likely minimal given the size of the transactions relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 03/22/2022 | First vesting date for some stock options. |
| 03/22/2023 | First vesting date for some stock options. |
| 09/24/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 02/03/2025 | Date of stock option exercise and sale of shares. |
| 02/04/2025 | Date of Form 4 filing. |
| 03/22/2028 | Expiration date for some stock options. |
| 03/22/2029 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.